Drug shortage
Flurazepam Hydrochloride Capsule · Rising Pharma Holdings, Inc.
FDA drug shortage · Current · updated Mar 4, 2025
Key facts
| Generic name | Flurazepam Hydrochloride Capsule |
|---|---|
| Proprietary name | Flurazepam Hydrochloride |
| Company | Rising Pharma Holdings, Inc. |
| Presentation | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01) |
| Dosage form | Capsule |
| Strength | 30 mg |
| Status | Current |
| Reason for shortage | Regulatory delay |
| Therapeutic category | Neurology Other |
| Package NDCs | 0378-4430-01 |
| First posted | Aug 3, 2022 |
| Last updated | Mar 4, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: